These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 17665607)
1. [Clinical significance of nitric oxide levels in patients with chronic glomerulonephritis]. Barbarash OL; Pavlova VIu; Chesnokova IuL; Bazdyrev ED; Malyshev IIu; Manukhina EB Klin Med (Mosk); 2007; 85(5):57-61. PubMed ID: 17665607 [TBL] [Abstract][Full Text] [Related]
2. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis]. Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960 [TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of serum and urinary biomarkers for water-salt metabolism in patients with proteinuric forms of chronic glomerulonephritis]. Pulin AA; Brovko MIu; Kustova TIu; Kozlovskaia LV; Fomin VV; Mukhin NA Ter Arkh; 2014; 86(6):24-9. PubMed ID: 25095652 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum and urinary neopterins in patients with chronic renal disease. Godai K; Uemasu J; Kawasaki H Clin Nephrol; 1991 Sep; 36(3):141-6. PubMed ID: 1934670 [TBL] [Abstract][Full Text] [Related]
5. [Role of IL-8 and defensins in pathogenesis of chronic glomerulonephritis and pyelonephritis]. Rebenok AZh; Tikhonov II; Chizh AS Ter Arkh; 1999; 71(8):62-7. PubMed ID: 10515041 [TBL] [Abstract][Full Text] [Related]
6. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression]. Bobkova IN; Chebotareva NV; Kozlovskaia LV; Varshavskiĭ VA; Golitsyna EP Ter Arkh; 2006; 78(5):9-14. PubMed ID: 16889042 [TBL] [Abstract][Full Text] [Related]
7. [Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis]. Smyr KV; Shcherbak AV; Kozlovskaia LV; Sokolova IA; Bobkova IN; Podorol'skaia LV Ter Arkh; 2010; 82(1):47-51. PubMed ID: 20364701 [TBL] [Abstract][Full Text] [Related]
8. [Clinical implications of urine matrix metalloproteinases and their inhibitors in patients with chronic glomerulonephritis]. Li OA; Bobkova IN; Kozlovckaia LV Ter Arkh; 2009; 81(8):10-4. PubMed ID: 19799193 [TBL] [Abstract][Full Text] [Related]
9. [Urinary fibronectin as an indicator of kidney fibrosis in nephritis]. Kozlovskaia LV; Bobkova IN; Varshavskiĭ VA; Proskurneva EP; Miroshnichenko NG; Chebotareva NV; Mukhin NA Ter Arkh; 1999; 71(6):34-8. PubMed ID: 10420453 [TBL] [Abstract][Full Text] [Related]
10. [Features of a cytokine profile in patients with chronic glomerulonephritis with progressive chronic renal failure]. Koriakova NN; Rozhdestvenskaia ED; Kazantseva SV; Bushueva TV; Valamina IE Ter Arkh; 2006; 78(5):14-7. PubMed ID: 16889043 [TBL] [Abstract][Full Text] [Related]
11. [Association of the complex of polymorphic markers of ACE genes, aldosteron synthetase and endothelial synthetase of nitric oxide with progression of chronic glomerulonephritis]. Kamysheva ES; Kutyrina IM; Nosikov VV; Shvetsov MIu; Gorashko NM; Ignat'ev IV; Voron'ko OE; Shilo VIu; Aliaev IuG; Shilov EM Ter Arkh; 2004; 76(9):16-20. PubMed ID: 15532370 [TBL] [Abstract][Full Text] [Related]
12. Analysis of nitric oxide in the exhaled air of patients with chronic glomerulonephritis. Kakoki M; Matsumoto A; Nagata D; Kobayakawa N; Kimura K; Momomura S; Hirata Y Clin Nephrol; 1999 Aug; 52(2):83-90. PubMed ID: 10480218 [TBL] [Abstract][Full Text] [Related]
13. [Tests for cell membrane destabilization in assessing activity-progression of chronic glomerulonephritis]. Sigitova ON; Maksudova AN; Miasoutova LI Ter Arkh; 2000; 72(6):26-30. PubMed ID: 10900644 [TBL] [Abstract][Full Text] [Related]
14. [Serum superoxide dismutase (SOD) activity in patients with renal disease by a spintrap method using electron spin resonance (ESR)]. Yokoyama K; Tomino Y; Yaguchi Y; Koide H; Ohmori D; Yamakura F Nihon Jinzo Gakkai Shi; 1993 Jul; 35(7):809-14. PubMed ID: 8411759 [TBL] [Abstract][Full Text] [Related]
15. [Urinary excretion of glycosaminoglycans in patients with chronic pyelonephritis and chronic glomerulonephritis]. Pavlov SB Klin Med (Mosk); 1998; 76(2):41-3. PubMed ID: 9553361 [TBL] [Abstract][Full Text] [Related]
16. [Blood and urine endothelin and nitric oxide levels in predialysis children with chronic renal failure]. Medyńska A; Kiliś-Pstrusińska K; Zwolińska D; Szczepańska M; Szprynger K Przegl Lek; 2006; 63 Suppl 3():159-61. PubMed ID: 16898519 [TBL] [Abstract][Full Text] [Related]
17. [Clinical investigation of urinary dipeptidyl aminopeptidase IV (DAP IV) activity in patients with primary glomerular diseases]. Nagata T Nihon Jinzo Gakkai Shi; 1990 Nov; 32(11):1161-8. PubMed ID: 1982015 [TBL] [Abstract][Full Text] [Related]
18. [The beta 2-microglobulin content of the blood serum and urine in patients with primary chronic and lupus glomerulonephritis]. Diadyk AI; Siniachenko OV; Shtoda LA; Siniachenko TIu; Khomenko MV; Iarovaia NF; Zviagina TV Vrach Delo; 1991 Sep; (9):61-4. PubMed ID: 1759435 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)]. Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409 [TBL] [Abstract][Full Text] [Related]